Soluble granzyme B and cytotoxic T lymphocyte activity in the pathogenesis of systemic lupus erythematosus

Cellular Immunology

Volumn 269, Issue 1, 2011, Pages 16-21

  Shah, Dilip ^a   Kiran, Ravi ^a   Wanchu, Ajay ^b   Bhatnagar, Archana ^a  

^a PANJAB UNIVERSITY   (India)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cytotoxic T lymphocyte; SLEDAI score; Soluble granzyme B; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; GRANZYME B;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMATOLOGIC DISEASE; HUMAN; INFLAMMATION; KIDNEY DISEASE; LYMPHADENOPATHY; MALE; MOUTH ULCER; NORMAL HUMAN; PATHOGENESIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SERUM; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX SCORE;

ADULT; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANZYMES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; T-LYMPHOCYTES, CYTOTOXIC; YOUNG ADULT;

EID: 79955470575     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.03.004     Document Type: Article

References (31)

1. Emlen W., Niebur J., Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 1994, 152:3685-3692.
2. Perniok A., Wedekind F., Herrmann M., Specker C., Schneider M. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998, 7:113-118.
3. Wirleitner B., Obermoser G., Bock G., Neurauter G., Schennach H., Sepp N., Fuchs D. Induction of apoptosis in human blood T cells by 7,8-dihydroneopterin: the difference between healthy controls and patients with systemic lupus erythematosus. Clin. Immunol. 2003, 107:152-159.
4. Ahsan H., Ali A., Ali R. Oxygen free radicals and systemic autoimmunity. Clin. Exp. Immunol. 2003, 131:398-404.
5. Graham K.L., Utz P.J. Sources of autoantigens in systemic lupus erythematosus. Curr. Opin. Rheumatol. 2005, 17:513-517.
6. Trapani J.A., Smyth M.J. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Nat. Rev. Immunol. 2002, 2:735-747.
7. Lord S.J., Rajotte R.V., Korbutt G.S., Bleackley R.C. Granzyme B: a natural born killer. Immunol. Rev. 2003, 193:31-38.
8. Andrade F., Roy S., Nicholson D., Thornberry N., Rosen A., Casciola-Rosen L. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 1998, 8:451-460.
9. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 1994, 179:1317.
10. Amoura Z., Combadiere C., Faure S., Parizot C., Miyara M., Raphael D., Ghillani P., Debre P., Piette J.C., Gorochov G. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Arthritis Rheum. 2003, 48:3487-3496.
11. Kohchiyama A., Oka D., Ueki H. T-cell subsets in lesions of systemic and discoid lupus erythematosus. J. Cutan. Pathol. 1985, 12:493-499.
12. Synkowski D.R., Provost T.T. Characterization of the inflammatory infiltrate in lupus erythematosus lesions using monoclonal antibodies. J. Rheumatol. 1983, 10:920-924.
13. Blanco P., Pitard V., Viallard J.F., Taupin J.L., Pellegrin J.L., Moreau J.F. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Care Res. 2005, 52:201-211.
14. Buzza M.S., Bird P.I. Extracellular granzymes: current perspectives. Biol. Chem. 2006, 387:827-837.
15. Tak P.P., Spaeny-Dekking L., Kraan M.C., Breedveld F.C., Froelich C.J., Hack C.E. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 1999, 116:366-370.
16. Goldbach-Mansky R., Suson S., Wesley R., Hack C.E., El-Gabalawy H.S., Tak P.P. Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis. Ann. Rheum. Dis. 2005, 64:715-721.
17. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
18. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992, 35:630-640.
19. Kay H.D. A new procedure to overlay diluted blood on Ficoll-hypaque gradients. J. Immunol. Methods 1980, 39:81-83.
20. Grassi M., Capello F., Bertolino L., Seia Z., Pippione M. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis. Clin. Exp. Dermatol. 2009, 34:910-914.
21. Wowk M.E., Trapani J.A. Cytotoxic activity of the lymphocyte toxin granzyme B. Microbes Infect. 2004, 6:752-758.
22. Steinman R.M., Turley S., Mellman I., Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 2000, 191:411-416.
23. Shresta S., Heusel J.W., Macivor D.M., Wesselschmidt R.L., Russell J.H., Ley T.J. Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis. Immunol. Rev. 1995, 146:211-221.
24. Mullbacher A., Waring P., ThaHla R., Tran T., Chin S., Stehle T., Museteanu C., Simon M.M. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc. Natl. Acad. Sci. USA 1999, 96:13950-13955.
25. Kahaleh M.B., Fan P.S. Mechanism of serum-mediated endothelial injury in scleroderma: identification of a granular enzyme in scleroderma skin and sera. Clin. Immunol. Immunopathol. 1997, 83:32-40.
26. Alpert S., Kang H.I., Weissman I., Fox R.I. Expression of granzyme A in salivary gland biopsies from patients with primary Sjogren's syndrome. Arthritis Rheum. 1994, 37:1046-1054.
27. Goebels N., Michaelis D., Engelhardt M., Huber S., Bender A., Pongratz D., Johnson M.A., Wekerle H., Tschopp J., Jenne D., Hohlfeld R. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J. Clin. Invest. 1996, 97:2905-2910.
28. Hagn M., Ebel V., Sontheimer K., Schwesinger E., Lunov O., Beyer T., Fabricius D., Barth T.F., Viardot A., Stilgenbauer S., Hepp J., Scharffetter-Kochanek K., Simmet T., Jahrsdorfer B. CD5(+) B cells from individuals with systemic lupus erythematosus express granzyme B. Eur. J. Immunol. 2010, 40:2060-2069.
29. Wenzel J., Uerlich M., Worrenkamper E., Freutel S., Bieber T., Tuting T. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein M×A. Br. J. Dermatol. 2005, 153:1011-1015.
30. Isaaz S., Baetz K., Olsen K., Podack E., Griffiths G.M. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation. Re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 1995, 25:1071-1079.
31. Spaeny-Dekking E.H., Hanna W.L., Wolbink A.M., Wever P.C., Kummer J.A., Swaak A.J., Middeldorp J.M., Huisman H.G., Froelich C.J., Hack C.E. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J. Immunol. 1998, 160:3610-3616.